{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:16:52Z","timestamp":1793114212186,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Oral squamous cell carcinoma (OSCC) in the background of oral submucous fibrosis (OSF) caused by areca nut chewing has a high incidence in Asia-Pacific countries. However, the molecular mechanism remains unclear. Here, we performed circRNA microarray analysis to screen the circRNA expression profiles in OSCC and OSF. We identified circEPSTI1 as a circRNA with consistent, sequential upregulation from normal buccal mucosa (NBM) to OSF to OSCC. Functionally, circEPSTI1 significantly promoted OSCC cell proliferation and invasion, as evidenced by the CCK8, colony formation, wound healing, and transwell assays with circEPSTI1 overexpression and silencing. OSCC patients with circEPSTI1<jats:sup>high<\/jats:sup> status exhibited poor prognoses. CircEPSTI1 sponged miR-942-5p and accelerated epithelial-mesenchymal transition (EMT) to increase LTBP2 expression in OSCC through phosphorylation of PI3K\/Akt\/mTOR signaling pathway components. Blocking the PI3K\/Akt\/mTOR signaling pathway with the dual PI3k\/mTOR inhibitor BEZ235 reversed OSCC progression induced by overexpression of circEPSTI1 and LTBP2. Collectively, these results indicate that the circEPSTI1\/miR-942-5p\/LTBP2 axis affects OSCC cell proliferation and invasion via the acceleration of EMT and the phosphorylation of PI3K\/Akt\/mTOR signaling pathway components. CircEPSTI1 may be an independent diagnostic and prognostic marker and a potential therapeutic target for OSCC patients with OSF.<\/jats:p>","DOI":"10.1038\/s41419-020-02851-w","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T12:02:54Z","timestamp":1598011374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["The circEPSTI1\/mir-942-5p\/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K\/Akt\/mTOR pathway"],"prefix":"10.1038","volume":"11","author":[{"given":"Jie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canhua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengzhong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaiye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"key":"2851_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1600-0714.1995.tb01132.x","volume":"24","author":"Y Ko","year":"1995","unstructured":"Ko, Y. et al. Betel quid chewing, cigarette smoking, and alcohol consumption related to oral cancer in Taiwan. J. Oral. Pathol. Med. 24, 450\u2013453 (1995).","journal-title":"J. Oral. Pathol. Med."},{"key":"2851_CR2","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.3390\/ijms20122940","volume":"16","author":"YH Shih","year":"2019","unstructured":"Shih, Y. H., Wong, T. H., Shieh, T. M. & Tseng, Y. H. Oral submucous fibrosis: a review on etiopathogenesis, diagnosis, and therapy. Int. J. Mol. Sci. 16, 2940 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"2851_CR3","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.tripleo.2006.11.045","volume":"106","author":"U Isaac","year":"2008","unstructured":"Isaac, U., Issac, J. S. & Ahmed, K. N. Histopathologic features of oral submucous fibrosis: a study of 35 biopsy specimens. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 106, 556\u2013560 (2008).","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod."},{"key":"2851_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1600-0714.2005.00325.x","volume":"34","author":"P Rajalalitha","year":"2005","unstructured":"Rajalalitha, P. & Vali, S. Molecular pathogenesis of oral submucous fibrosis\u2013a collagen metabolic disorder. J. Oral. Pathol. Med. 34, 321\u2013328 (2005).","journal-title":"J. Oral. Pathol. Med."},{"key":"2851_CR5","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/0030-4220(66)90367-7","volume":"22","author":"JJ Pindborg","year":"1966","unstructured":"Pindborg, J. J. & Sirsat, S. M. Oral submucous fibrosis. Oral. Surg. Oral. Med. Oral. Pathol. 22, 764\u2013779 (1966).","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol."},{"key":"2851_CR6","first-page":"735","volume":"74","author":"A Auluck","year":"2008","unstructured":"Auluck, A., Rosin, M. P., Zhang, L. & Sumanth, K. N. Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature. J. Can. Dent. Assoc. 74, 735\u2013740 (2008).","journal-title":"J. Can. Dent. Assoc."},{"key":"2851_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0528.1980.tb01249.x","volume":"8","author":"World Health Organization.","year":"1980","unstructured":"World Health Organization. Guide to epidemiology and diagnosis of oral mucosal diseases and conditions. Community Dent. Oral. Epidemiol. 8, 1\u201326 (1980).","journal-title":"Community Dent. Oral. Epidemiol."},{"key":"2851_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1601-0825.2009.01563.x","volume":"15","author":"C Scully","year":"2009","unstructured":"Scully, C. & Bagan, J. Oral squamous cell carcinoma: an overview of current understanding of aetiopathogenesis and clinical implications. Oral. Dis. 15, 388\u2013399 (2009).","journal-title":"Oral. Dis."},{"key":"2851_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3322\/caac.20121","volume":"61","author":"R Siegel","year":"2011","unstructured":"Siegel, R., Ward, E., Brawley, O. & Jemal, A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin. 61, 212\u2013236 (2011).","journal-title":"CA Cancer J. Clin."},{"key":"2851_CR10","doi-asserted-by":"publisher","unstructured":"Jun, Y. et al. Do betel quid and areca nut chewing deteriorate prognosis of oral cancer? A systematic review, meta-analysis, and research agenda. Oral Dis. https:\/\/doi.org\/10.1111\/odi.13456 (2020).","DOI":"10.1111\/odi.13456"},{"key":"2851_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"EP Consortium","year":"2012","unstructured":"Consortium, E. P. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57\u201374 (2012).","journal-title":"Nature"},{"key":"2851_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-103","volume":"10","author":"J Sana","year":"2012","unstructured":"Sana, J., Faltejskova, P., Svoboda, M. & Slaby, O. Novel classes of non-coding RNAs and cancer. J. Transl. Med. 10, 103 (2012).","journal-title":"J. Transl. Med."},{"key":"2851_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrm.2015.32","volume":"17","author":"LL Chen","year":"2016","unstructured":"Chen, L. L. The biogenesis and emerging roles of circular RNAs. Nat. Rev. Mol. Cell. Biol. 17, 205\u2013211 (2016).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"2851_CR14","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.29270","volume":"66","author":"D Han","year":"2017","unstructured":"Han, D. et al. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology 66, 1151\u20131164 (2017).","journal-title":"Hepatology"},{"key":"2851_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/hepr.12871","volume":"47","author":"T Yao","year":"2017","unstructured":"Yao, T., Chen, Q. Q., Fu, L. Y. & Guo, J. M. Circular RNAs: biogenesis, properties, roles, and their relationships with liver diseases. Hepatol. Res. 47, 497\u2013504 (2017).","journal-title":"Hepatol. Res."},{"key":"2851_CR16","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1158\/1078-0432.CCR-16-2541","volume":"23","author":"W Weng","year":"2017","unstructured":"Weng, W. et al. Circular RNA ciRS-7-A promising prognostic biomarker and a potential therapeutic target in colorectal cancer. Clin. Cancer Res. 23, 3918\u20133928 (2017).","journal-title":"Clin. Cancer Res."},{"key":"2851_CR17","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen, T. B. et al. Natural RNA circles function as efficient microRNA sponges. Nature 495, 384\u2013388 (2013).","journal-title":"Nature"},{"key":"2851_CR18","first-page":"2470","volume":"24","author":"X Tan","year":"2020","unstructured":"Tan, X., Zhou, C., Liang, Y., Lai, Y. F. & Liang, Y. Circ_0001971 regulates oral squamous cell carcinoma progression and chemosensitivity by targeting miR-194\/miR-204 in vitro and in vivo. Eur. Rev. Med. Pharmacol. Sci. 24, 2470\u20132481 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"2851_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2273-y","volume":"11","author":"QS Peng","year":"2020","unstructured":"Peng, Q. S. et al. circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway. Cell. Death. Dis. 11, 112 (2020).","journal-title":"Cell. Death. Dis."},{"key":"2851_CR20","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1158\/1055-9965.EPI-07-2908","volume":"17","author":"L Ning","year":"2008","unstructured":"Ning, L. et al. Discovery of novel biomarkers in oral submucous fibrosis by microarray analysis. Cancer Epidemiol. Biomark. Prev. 17, 2249\u20132259 (2008).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"2851_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054705","volume":"8","author":"VK Vincent","year":"2013","unstructured":"Vincent, V. K. et al. Genome wide analysis of chromosomal alterations in oral squamous cell carcinomas revealed over expression of MGAM and ADAM9. PLoS ONE 8, e54705 (2013).","journal-title":"PLoS ONE"},{"key":"2851_CR22","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/s12885-016-2650-1","volume":"16","author":"W Liu","year":"2016","unstructured":"Liu, W. et al. Quantitative proteomic analysis for novel biomarkers of buccal squamous cell carcinoma arising in background of oral submucous fibrosis. BMC Cancer 16, 584\u2013594 (2016).","journal-title":"BMC Cancer"},{"key":"2851_CR23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1006\/geno.2002.6755","volume":"79","author":"HL Nielsen","year":"2002","unstructured":"Nielsen, H. L., Ronnov, L., Villadsen, R. & Petersen, O. W. Identification of EPSTI1, a novel gene induced by epithelial-stromal interaction in human breast cancer. Genomics 79, 703\u2013710 (2002).","journal-title":"Genomics"},{"key":"2851_CR24","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.ajhg.2012.04.016","volume":"90","author":"G Kosova","year":"2012","unstructured":"Kosova, G., Scott, N. M., Niederberger, C., Prins, G. S. & Ober, C. Genome-wide association study identifies candidate genes for male fertility traits in humans. Am. J. Hum. Genet. 90, 950\u2013961 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"2851_CR25","first-page":"2281","volume":"24","author":"G Gangqiang","year":"2019","unstructured":"Gangqiang, G. et al. Hsa_circ_0000479 as a novel diagnostic biomarker of systemic lupus erythematosus. Front. Immunol. 24, 2281 (2019).","journal-title":"Front. Immunol."},{"key":"2851_CR26","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1111\/jcmm.14260","volume":"23","author":"J Xie","year":"2019","unstructured":"Xie, J. et al. circEPSTI1 regulates ovarian cancer progression via decoying miR\u2010942. J. Cell. Mol. Med. 23, 3597\u20133602 (2019).","journal-title":"J. Cell. Mol. Med."},{"key":"2851_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13046-018-0838-8","volume":"37","author":"N Bai","year":"2018","unstructured":"Bai, N. et al. circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346. J. Exp. Clin. Cancer Res. 37, 172 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2851_CR28","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/cdd.2017.86","volume":"24","author":"Q Yang","year":"2017","unstructured":"Yang, Q. et al. A circular RNA promotes tumorigenesis by inducing c-myc nuclear translocation. Cell. Death. Differ. 24, 1609\u20131620 (2017).","journal-title":"Cell. Death. Differ."},{"key":"2851_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.devcel.2019.04.010","volume":"49","author":"W Lu","year":"2019","unstructured":"Lu, W. & Kang, Y. Epithelial-mesenchymal plasticity in cancer progression and metastasis. Dev. Cell. 49, 361\u2013374 (2019).","journal-title":"Dev. Cell."},{"key":"2851_CR30","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/j.1460-2075.1991.tb08049.x","volume":"10","author":"K Miyazono","year":"1991","unstructured":"Miyazono, K., Olofsson, A., Colosetti, P. & Heldin, C. H. A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1. EMBO J. 10, 1091\u20131101 (1991).","journal-title":"EMBO J."},{"key":"2851_CR31","doi-asserted-by":"publisher","first-page":"45052","DOI":"10.18632\/oncotarget.8855","volume":"7","author":"L Han","year":"2016","unstructured":"Han, L. et al. LTBP2 is a prognostic marker in head and neck squamous cell carcinoma. Oncotarget 7, 45052\u201345059 (2016).","journal-title":"Oncotarget"},{"key":"2851_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/ijc.28953","volume":"136","author":"AN Costa","year":"2015","unstructured":"Costa, A. N. et al. Osteopontin and latent-TGF \u03b2 binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma. Int. J. Cancer 136, 172\u2013181 (2015).","journal-title":"Int. J. Cancer"},{"key":"2851_CR33","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3727\/096504016X14755368915591","volume":"25","author":"F Wan","year":"2017","unstructured":"Wan, F. et al. Knockdown of latent transforming growth factor-\u03b2 (TGF-\u03b2)-binding protein 2 (LTBP2) inhibits invasion and tumorigenesis in thyroid carcinoma cells. Oncol. Res. 25, 503\u2013510 (2017).","journal-title":"Oncol. Res."},{"key":"2851_CR34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/ijc.25698","volume":"129","author":"SH Chan","year":"2011","unstructured":"Chan, S. H. et al. The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome. Int. J. Cancer 129, 565\u2013573 (2011).","journal-title":"Int. J. Cancer"},{"key":"2851_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127239","volume":"10","author":"R Kan","year":"2015","unstructured":"Kan, R. et al. NF-\u03baB p65 subunit is modulated by latent transforming growth factor-\u03b2 binding protein 2 (LTBP2) in nasopharyngeal carcinoma HONE1 and HK1 cells. PLoS ONE 10, e0127239 (2015).","journal-title":"PLoS ONE"},{"key":"2851_CR36","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.3892\/ijo.2014.2668","volume":"45","author":"A Glassmann","year":"2014","unstructured":"Glassmann, A., Winter, J., Kraus, D., Veit, N. & Probstmeier, R. Pharmacological suppression of the Ras\/MAPK pathway in thyroid carcinoma cells can provoke opposite effects on cell migration and proliferation: the appearance of yin-yang effects and the need of combinatorial treatments. Int. J. Oncol. 45, 2587\u20132595 (2014).","journal-title":"Int. J. Oncol."},{"key":"2851_CR37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tips.2014.11.004","volume":"36","author":"F Chiarini","year":"2015","unstructured":"Chiarini, F., Evangelisti, C., McCubrey, J. A. & Martelli, A. M. Current treatment strategies for inhibiting mTOR in cancer. Trends Pharmacol. Sci. 36, 124\u2013135 (2015).","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02851-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02851-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02851-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T15:12:38Z","timestamp":1670253158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02851-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8]]}},"alternative-id":["2851"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-02851-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"assertion":[{"value":"4 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"682"}}